AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Cleerly CEO, James Min, MD, was named to Business Insider's inaugural AI 100 list, recognizing Cleerly as a leader in the AI space for the work we're doing to ensure AI develops steadily and responsibly. See the full list here.
Photo Credit: Sua Balac for Insider
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...
Nasdaq interviews CEO Dr. James K. Min, one of their 18 “Brilliant Minds in Healthcare,” about Cleerly’s founding, his vision for the company, and...